| Date Filed | Type | Description |
| 05/25/2023 |
4
| Keyt Bruce (Chief Scientific Officer) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Granted 960 shares
@ $11.71, valued at
$11.2k
Sold 970 shares
@ $12.3005, valued at
$11.9k
Sold 12 shares
@ $13.005, valued at
$156.1 |
|
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2023 |
4
| Keyt Bruce (Chief Scientific Officer) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Sold 1,293 shares
@ $18.732, valued at
$24.2k
|
|
| 01/09/2023 |
4
| Keyt Bruce (Chief Scientific Officer) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Exercised 33,756 options to buy
@ $0.93, valued at
$31.4k
|
|
| 12/20/2022 |
4
| Keyt Bruce (Chief Scientific Officer) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Sold 3,454 shares
@ $18.7746, valued at
$64.8k
Sold 1,917 shares
@ $19.3595, valued at
$37.1k
|
|
| 12/16/2022 |
4
| Keyt Bruce (Chief Scientific Officer) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Exercised 25,000 options to buy
@ $0.93, valued at
$23.3k
|
|
| 11/28/2022 |
4
| Keyt Bruce (Chief Scientific Officer) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Sold 600 shares
@ $21.3765, valued at
$12.8k
Sold 277 shares
@ $21.9914, valued at
$6.1k
|
|
| 10/06/2022 |
4
| Keyt Bruce (Chief Scientific Officer) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Sold 25,000 shares
@ $22.8392, valued at
$571k
Exercised 25,000 options to buy
@ $0.93, valued at
$23.3k
|
|
| 09/08/2022 |
4
| Keyt Bruce (Chief Scientific Officer) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Sold 5,000 shares
@ $19.0642, valued at
$95.3k
Sold 10,000 shares
@ $19.0392, valued at
$190.4k
Sold 7,265 shares
@ $19.5727, valued at
$142.2k
Sold 2,735 shares
@ $20.3407, valued at
$55.6k
Exercised 5,000 options to buy
@ $0.93, valued at
$4.7k
Exercised 10,000 options to buy
@ $0.93, valued at
$9.3k
Exercised 10,000 options to buy
@ $0.93, valued at
$9.3k
|
|
| 08/22/2022 |
4
| Keyt Bruce (Chief Scientific Officer) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Sold 10,000 shares
@ $22.5352, valued at
$225.4k
Sold 8,700 shares
@ $22.8212, valued at
$198.5k
Sold 6,300 shares
@ $20.7065, valued at
$130.5k
Exercised 10,000 options to buy
@ $0.93, valued at
$9.3k
Exercised 8,700 options to buy
@ $0.93, valued at
$8.1k
Exercised 6,300 options to buy
@ $0.93, valued at
$5.9k
|
|
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/08/2022 |
4
| Keyt Bruce (Chief Scientific Officer) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Sold 2,500 shares
@ $25, valued at
$62.5k
Exercised 2,500 options to buy
@ $0.93, valued at
$2.3k
|
|
| 04/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/19/2021 |
4
| Keyt Bruce (Chief Scientific Officer) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Granted 10,000 shares
@ $0 |
|
| 11/17/2021 |
4
| Keyt Bruce (Chief Scientific Officer) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Granted 139 shares
@ $50.99, valued at
$7.1k
|
|
| 11/03/2021 |
4
| Keyt Bruce (Chief Scientific Officer) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 1,174 shares
@ $49.78, valued at
$58.4k
Sold 1,326 shares
@ $51.3701, valued at
$68.1k
Exercised 2,500 options to buy
@ $0.93, valued at
$2.3k
|
|
| 10/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/18/2020 |
4
| Keyt Bruce (Chief Scientific Officer) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 882 shares
@ $89.38, valued at
$78.8k
Sold 1,618 shares
@ $86.1, valued at
$139.3k
Exercised 2,500 options to buy
@ $0.93, valued at
$2.3k
|
|
| 11/17/2020 |
4
| Keyt Bruce (Chief Scientific Officer) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Granted 132 shares
@ $45.45, valued at
$6k
|
|
| 10/05/2020 |
4
| Keyt Bruce (Chief Scientific Officer) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Sold 1,000 shares
@ $73.59, valued at
$73.6k
|
|
|